Laurion Capital Management LP - SCPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,059,563
-37.0%
148,815
-9.8%
0.01%
-33.3%
Q2 2023$1,681,350
+12.3%
165,0000.0%0.01%
-10.0%
Q1 2023$1,496,550
+26.5%
165,0000.0%0.01%
+66.7%
Q4 2022$1,183,050165,0000.01%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RA Capital Management 2,857,143$35,429,0002.71%
Orbimed Advisors 3,409,865$42,282,0000.52%
AWM Investment Company, Inc. 213,317$2,645,0000.51%
DAFNA Capital Management LLC 55,844$692,0000.34%
ESSEX INVESTMENT MANAGEMENT CO LLC 40,373$501,0000.07%
Alyeska Investment Group, L.P. 223,438$2,771,0000.02%
PRELUDE CAPITAL MANAGEMENT, LLC 24,330$302,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 69,500$862,0000.01%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 36,206$449,0000.00%
PEDDOCK CAPITAL ADVISORS, LLC 100$1,0000.00%
View complete list of SCPHARMACEUTICALS INC shareholders